GlobeNewswire Inc | Sep 2, 2021 07:00AM EDT

September 02, 2021

SOUTH SAN FRANCISCO, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Alector, Inc.(Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced that management will participate in the following upcoming virtual investor conferences:

-- Citis 16th Annual Biopharma Virtual Conference Wednesday, September 8, 2021 at 11:35 a.m. ET, Whats Next for Neurodegenerative Diseases PanelThursday, September 9, 2021 at 1:25 p.m. ET, Fireside Chat -- The 2021 Wells Fargo Virtual Healthcare Conference Friday, September 10, 2021 at 2:00 p.m. ET, Corporate Presentation -- The Morgan Stanley 19th Annual Global Healthcare Conference Monday, September 13, 2021 at 11:45 a.m. ET, Fireside Chat

Live webcasts of each conference presentation will be available on the Events & Presentations page within the Investors section of the Alector website at http://investors.alector.com. Replays of the webcasts will be available on the Alector website for 30 days following the presentation dates.

AboutAlectorAlectoris a clinical-stage biotechnology company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegenerative diseases. Immuno-neurology targets immune dysfunction as a root cause of multiple pathologies that are drivers of degenerative brain disorders.Alector has discovered and is developing a broad portfolio of innate immune system programs, designed to functionally repair genetic mutations that cause dysfunction of the brains immune system and enable the rejuvenated immune cells to counteract emerging brain pathologies. Alectors immuno-neurology product candidates are supported by biomarkers and target genetically defined patient populations in frontotemporal dementia and Alzheimers disease. This scientific approach is also the basis for the companys immuno-oncology programs.Alectoris headquartered inSouthSan Francisco,California. For additional information, please visitwww.alector.com.

Alector ContactsMichelle CorralVP, Communications and Investor Relations650-808-7016michelle.corral@alector.com

1AB (media)Dan Budwick973-271-6085dan@1abmedia.com

Argot Partners (investors)Laura Perry/Eric KasperArgot Partners212.600.1902alector@argotpartners.com